Impact of ultrahigh baseline PSA levels on biochemical and clinical outcomes in two Radiation Therapy Oncology Group prostate clinical trials

PURPOSE: To assess ultra-high (UH; PSA ≥ 50 ng/ml) patient outcomes compared to other high-risk patients and to identify outcome predictors. METHODS AND MATERIALS: PCP from two Phase III RTOG clinical trials (9202 and 9413) were divided into two groups; high-risk patients with and without UH baselin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Rodrigues, George, Bae, Kyounghwa, Roach, Mack, Lawton, Colleen, Donnelly, Bryan, Grignon, David, Hanks, Gerald, Porter, Arthur, Lepor, Herbert, Sandler, Howard
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2952349/
https://ncbi.nlm.nih.gov/pubmed/20615632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2010.02.034
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares